49,006
edits
(6 intermediate revisions by the same user not shown) | |||
Line 11: | Line 11: | ||
Treatment: | Treatment: | ||
*Sebelipase alfa - a replacement enzyme. | *Sebelipase alfa - a replacement enzyme.<ref name=pmid27878737>{{Cite journal | last1 = Frampton | first1 = JE. | title = Sebelipase Alfa: A Review in Lysosomal Acid Lipase Deficiency. | journal = Am J Cardiovasc Drugs | volume = 16 | issue = 6 | pages = 461-468 | month = Dec | year = 2016 | doi = 10.1007/s40256-016-0203-2 | PMID = 27878737 }}</ref><ref name=pmid26352813>{{Cite journal | last1 = Burton | first1 = BK. | last2 = Balwani | first2 = M. | last3 = Feillet | first3 = F. | last4 = Barić | first4 = I. | last5 = Burrow | first5 = TA. | last6 = Camarena Grande | first6 = C. | last7 = Coker | first7 = M. | last8 = Consuelo-Sánchez | first8 = A. | last9 = Deegan | first9 = P. | title = A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency. | journal = N Engl J Med | volume = 373 | issue = 11 | pages = 1010-20 | month = Sep | year = 2015 | doi = 10.1056/NEJMoa1501365 | PMID = 26352813 }}</ref> | ||
==Gross== | ==Gross== | ||
*[[ | *Hepatosplenomegaly (hepatomegaly, [[splenomegaly]]). | ||
==Microscopic== | ==Microscopic== | ||
===Liver=== | |||
Features: | Features: | ||
*Microvesicular or mixed steatosis (microvesicular and macrovesicular). | *Microvesicular or mixed steatosis (microvesicular and macrovesicular). | ||
Line 23: | Line 24: | ||
Notes: | Notes: | ||
*Usually microvesicular predominant. | *Usually microvesicular predominant. | ||
*Portal fibrosis is more typical than central fibrosis usually seen in [[ | *Portal fibrosis is more typical than central fibrosis usually seen in [[MASH]]. | ||
DDx: | DDx: | ||
*[[Microvesicular steatosis]]. | *[[Microvesicular steatosis]]. | ||
===Small bowel=== | |||
Features: | |||
*Lipid accumulation - similar to [[Whipple's disease]].{{fact}}<ref name=pmid25450374>{{Cite journal | last1 = Lopez | first1 = AM. | last2 = Posey | first2 = KS. | last3 = Turley | first3 = SD. | title = Deletion of sterol O-acyltransferase 2 (SOAT2) function in mice deficient in lysosomal acid lipase (LAL) dramatically reduces esterified cholesterol sequestration in the small intestine and liver. | journal = Biochem Biophys Res Commun | volume = 454 | issue = 1 | pages = 162-6 | month = Nov | year = 2014 | doi = 10.1016/j.bbrc.2014.10.063 | PMID = 25450374 }}</ref> | |||
==See also== | ==See also== |
edits